Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Auditor change
|
|
Acorda Therapeutics, Inc. (ACOR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| CANYON CAPITAL ADVISORS LLC reports a 0% stake in Acorda Therapeutics Inc |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| CANYON CAPITAL ADVISORS LLC reports a 5.8% stake in Acorda Therapeutics Inc |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 4.1% stake in Acorda Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| UBS OCONNOR LLC reports a 0% stake in Acorda Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/28/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 1.9% stake in Acorda Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| SYMPHONY ASSET MANAGEMENT LLC reports a 0% stake in Acorda Therapeutics, Inc. |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/10/2020 |
SC 13G/A
| VANGUARD GROUP INC reports a 4.7% stake in Acorda Therapeutics Inc. |
| 08/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/10/2020 |
SC 13G/A
| FMR LLC reports a 6.1% stake in ACORDA THERAPEUTICS INC |
| 06/09/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.8% stake in ACORDA THERAPEUTICS INC |
| 02/14/2020 |
SC 13G/A
| Partner Fund Management, L.P. reports a 4% stake in Acorda Therapeutics, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 13.4% stake in ACORDA THERAPEUTICS INC |
| 02/04/2020 |
SC 13G/A
| BlackRock Inc. reports a 16.3% stake in ACORDA THERAPEUTICS INC |
| 11/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Partner Fund Management, L.P. reports a 6.1% stake in Acorda Therapeutics, Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| VANGUARD GROUP INC reports a 12.8% stake in Acorda Therapeutics Inc |
| 02/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/24/2019 |
SC 13G/A
| BlackRock Inc. reports a 14% stake in ACORDA THERAPEUTICS INC |
| 07/10/2018 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.3% stake in Acorda Therapeutics Inc |
| 02/14/2018 |
SC 13G/A
| Partner Fund Management, L.P. reports a 7.5% stake in Acorda Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 0.4% stake in Acorda Therapeutics, Inc. |
|
|
|